Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM

Abstract Introduction Multiple sclerosis (MS) clinical trials have included low numbers of patients from racial and ethnic minority populations; therefore, it is uncertain whether differences exist in response to disease-modifying therapies. We evaluated the real-world safety and effectiveness of di...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mitzi J. Williams, Lilyana Amezcua, Angel Chinea, Stanley Cohan, Annette Okai, Darin T. Okuda, Wendy Vargas, Nick Belviso, Ivan Božin, Xiaotong Jiang, James B. Lewin, Jennifer Lyons, Changyu Shen, Sarah M. England, Nydjie Grimes
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2023-06-01
coleção:	Neurology and Therapy
Assuntos:	Dimethyl fumarate Multiple sclerosis Safety and effectiveness Minority populations
Acesso em linha:	https://doi.org/10.1007/s40120-023-00517-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!